GUARDANT HEALTH INC (GH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for GH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GH | Director; 24th Secretary of the U.S. Department of Health and Human Services | 58 | ["24th Secretary of the U.S. Department of Health and Human Services (2018-2021)","President of Lilly USA, LLC (2007-2017)","Deputy Secretary of HHS (2005-2007)","General Counsel of HHS (2001-2005)","Partner at Wiley Rein LLP (1999-2001)","Adjunct Professor of Business and Distinguished Executive-in-Residence at the University of Miami Herbert Business School"] | ["Nominating and Corporate Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Alex M. Azar II has served as a member of our Board since September 2025. Alex M. Azar II served as the 24th Secretary of the U.S. Department of Health and Human Services (HHS) from 2018 to 2021. Prior to his appointment as HHS Secretary, Secretary Azar held multiple executive leadership roles including as President of Lilly USA, LLC, the largest affiliate of Eli Lilly and Company, from 2007 to 2017, and Deputy Secretary of HHS from 2005 to 2007, General Counsel of HHS from 2001 to 2005, and Partner at Wiley Rein LLP from 1999 to 2001. He currently serves as an Adjunct Professor of Business and Distinguished Executive-in-Residence at the University of Miami Herbert Business School. Secretary Azar is a member of the Board of Trustees at the Aspen Institute, chairman of the board of the Healthcare Leadership Council, chairman of the board of LifeScience Logistics, a member of the boards of Global Health/MCS and AbsoluteCare, as an advisor at Foresite Capital, Chair of the Board of the Healthcare Leadership Council, a member of the advisory board of Milken s Institute s FasterCures, and a member of the Department of Health Policy Advisory Board at the Stanford University School of Medicine. We believe that Secretary Azar brings an important blend of government and healthcare industry experience to our Board.